celiprolol has been researched along with Cardiomegaly in 4 studies
Celiprolol: A cardioselective beta-1 adrenergic antagonist that has intrinsic sympathomimetic activity. It is used in the management of ANGINA PECTORIS and HYPERTENSION.
Cardiomegaly: Enlargement of the HEART, usually indicated by a cardiothoracic ratio above 0.50. Heart enlargement may involve the right, the left, or both HEART VENTRICLES or HEART ATRIA. Cardiomegaly is a nonspecific symptom seen in patients with chronic systolic heart failure (HEART FAILURE) or several forms of CARDIOMYOPATHIES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "These findings indicated that celiprolol attenuates cardiac myocyte hypertrophy both in vitro and in vivo and halts the process leading from hypertrophy to heart failure." | 7.72 | Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice. ( Asakura, M; Asano, Y; Asanuma, H; Hori, M; Kim, J; Kitakaze, M; Kitamura, S; Liao, Y; Minamino, T; Ogai, A; Sanada, S; Shintani, Y; Takashima, S; Tomoike, H, 2004) |
| "These findings indicated that celiprolol attenuates cardiac myocyte hypertrophy both in vitro and in vivo and halts the process leading from hypertrophy to heart failure." | 3.72 | Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice. ( Asakura, M; Asano, Y; Asanuma, H; Hori, M; Kim, J; Kitakaze, M; Kitamura, S; Liao, Y; Minamino, T; Ogai, A; Sanada, S; Shintani, Y; Takashima, S; Tomoike, H, 2004) |
| "Long-term treatment with celiprolol, a new cardioselective beta blocker, significantly reduced blood pressure in 14 patients with essential hypertension (World Health Organization stages I to II)." | 3.67 | Reduction of left ventricular hypertrophy in hypertensive patients after treatment with celiprolol. ( Bischof, F; Burghagen, H; Freischuetz, G; Herrmann, JM; Mayer, EO; Von Heymann, F, 1988) |
| "Celiprolol (C) is a new selective beta 1-blocker with partial beta 2-agonistic activity." | 1.28 | Short-term effects of celiprolol on blood pressure and left ventricular performance in hypertensive cardiomyopathy. ( Alay, D; Cuenca, P; Lorenzo, JG; Plaza, L; RodrÃguez Rodrigo, FJ; Ruiz, I; Terol, I, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liao, Y | 1 |
| Asakura, M | 1 |
| Takashima, S | 1 |
| Ogai, A | 1 |
| Asano, Y | 1 |
| Shintani, Y | 1 |
| Minamino, T | 1 |
| Asanuma, H | 1 |
| Sanada, S | 1 |
| Kim, J | 1 |
| Kitamura, S | 1 |
| Tomoike, H | 1 |
| Hori, M | 1 |
| Kitakaze, M | 1 |
| RodrÃguez Rodrigo, FJ | 1 |
| Ruiz, I | 1 |
| Lorenzo, JG | 1 |
| Alay, D | 1 |
| Terol, I | 1 |
| Cuenca, P | 1 |
| Plaza, L | 1 |
| Vyssoulis, GP | 1 |
| Karpanou, EA | 1 |
| Pitsavos, CE | 1 |
| Kourtis, TK | 1 |
| Paleologos, AA | 1 |
| Toutouzas, PK | 1 |
| Herrmann, JM | 1 |
| Bischof, F | 1 |
| Von Heymann, F | 1 |
| Mayer, EO | 1 |
| Freischuetz, G | 1 |
| Burghagen, H | 1 |
4 other studies available for celiprolol and Cardiomegaly
| Article | Year |
|---|---|
Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Cardiomegaly; Celiprol | 2004 |
Short-term effects of celiprolol on blood pressure and left ventricular performance in hypertensive cardiomyopathy.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Cardiomegaly; Celiprolol; Echocardiography, Doppler; Fe | 1992 |
Comparison of ketanserin and celiprolol on regression of left ventricular hypertrophy in older hypertensive patients.
Topics: Adrenergic beta-Antagonists; Aged; Blood Pressure; Cardiomegaly; Celiprolol; Echocardiography; Femal | 1992 |
Reduction of left ventricular hypertrophy in hypertensive patients after treatment with celiprolol.
Topics: Adult; Antihypertensive Agents; Cardiomegaly; Celiprolol; Echocardiography; Female; Humans; Hyperten | 1988 |